Maftivimab
Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and agent Administration (FDA) -approved agent. Maftivimab, also named as Atoltivimab, Odesivimab (Inmazeb), can be used for research of Zaire ebolavirus infection[1].
Product Specifications
CAS Number
2135632-36-7
Product Name Alternative
REGN3470-3471-3479
UNSPSC
12352203
Target
Filovirus
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/maftivimab.html
Purity
96.89
Solubility
10 mM in DMSO
Smiles
[Maftivimab]
Molecular Weight
(143.94 kDa)
References & Citations
[1]Saxena D, et al. Atoltivimab/maftivimab/odesivimab (Inmazeb) combination to treat infection caused by Zaire ebolavirus. Drugs Today (Barc) . 2021 Aug;57 (8) :483-490.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Isoform
ZEBOV
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
